News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Markets showed limited movement in the past hour amid lack of major headlines.
  • US equity futures were little changed as trading volumes remained near recent averages.
  • Treasuries were largely flat with the 10-year yield steady around the previous close.
  • Oil and gold prices were little changed amid no new geopolitical catalysts.
  • Major currencies traded rangebound against the dollar without fresh central bank comments.
  • No significant political or economic releases appeared in the past hour to shift market direction.

Latest Articles

Needham Names Five Biotech Favorites Heading Into H2 2026

Needham Names Five Biotech Favorites Heading Into H2 2026

Needham & Company has identified five biotechnology stocks as its top picks for the second half of 2026, retaining Buy ratings and issuing price targets for each name. Catalysts cited by the firm include Phase 3 and Phase 2 data readouts across epilepsy, Alzheimer’s disease psychosis, systemic lupus erythematosus, binge eating disorder, and orexin-…

GTCR Reportedly in Talks to Buy SPS Commerce

GTCR Reportedly in Talks to Buy SPS Commerce

Private equity firm GTCR is reportedly in negotiations to acquire supply-chain software provider SPS Commerce. Sources say a deal could be announced soon, though talks remain unfinished and could collapse or attract competing bidders. SPS, based in Minneapolis, has been working with an investment bank to evaluate a possible sale amid pressure from …

Microsoft: AI Engine, Strong Cash Flow and a Cheap Entry Around $492

Microsoft: AI Engine, Strong Cash Flow and a Cheap Entry Around $492

Microsoft remains the safest scaled play on AI infrastructure and enterprise software. At $495, the stock offers a reasonable risk-reward: durable free cash flow, a healthy balance sheet and secular exposure to AI and cloud adoption. Technicals show near-term consolidation; we prefer a limit entry near $492.44, a $470 stop and a $540 target over th…

Alkermes: A Patient Long on CNS Upside and Optionality From Recent M&A

Alkermes: A Patient Long on CNS Upside and Optionality From Recent M&A

Alkermes trades like a commercial-stage CNS company with a sizable market cap ($7.7B), steady free cash flow (~$222M last reported) and an active pipeline. The stock sits below its 52-week high ($55.67) after a year of M&A and pipeline repositioning. I view ALKS as a long with a 180-trading-day horizon: the base business finances optionality, while…

LUNR: Backlog Means Growth, Execution Still Governs the Outcome

LUNR: Backlog Means Growth, Execution Still Governs the Outcome

Intuitive Machines finished Q2 with a record $1.8 billion backlog and $920 million in awards, setting the revenue runway for 2026 and beyond. Revenue growth is real (Q2 revenues of $206.2M, +310% YoY) and the company expects 25-30% of backlog to convert to 2026 revenue. That makes LUNR a tactical long for patient traders who accept execution risk: …

Treasury's Enlarged Long-End Buyback Fails to Quell Bond Market Unease

Treasury's Enlarged Long-End Buyback Fails to Quell Bond Market Unease

The U.S. Treasury increased the maximum size of its long-dated debt buyback to $6 billion from $2 billion, a move that fell short of calming investors. After the operation, in which $5.187 billion of 10- and 20-year securities were repurchased, long-term Treasury yields rose to multi-week and multi-month highs, underscoring market skepticism that m…

Taysha Gene Therapies: A Patient Bull Trade on TSHA-102 Optionality

Taysha Gene Therapies: A Patient Bull Trade on TSHA-102 Optionality

Taysha (TSHA) is a clinical-stage AAV gene therapy company whose lead program, TSHA-102 for Rett syndrome, has advanced through pivotal dosing and gained regulatory alignment on manufacturing and BLA strategy. With roughly $320M in cash, a completed $200M offering in June, and a market cap near $1.6B, TSHA offers asymmetric upside if clinical reado…

US Banking Regulators Outline New Principles for Third-Party Risk Management

US Banking Regulators Outline New Principles for Third-Party Risk Management

Federal banking regulators on Friday released a proposed, principles-based set of guidelines intended to help banks and credit unions align third-party risk management to the risks presented by individual vendor relationships. The Federal Reserve, OCC, FDIC and NCUA said the guidance is non-binding and would replace existing third-party risk guidan…

Colgate-Palmolive Weighs Sale of Select Personal-care Brands in >$1B Review

Colgate-Palmolive Weighs Sale of Select Personal-care Brands in >$1B Review

Colgate-Palmolive is evaluating the potential sale of several mass-market personal-care brands, including Softsoap, Irish Spring and Speed Stick. The company has engaged Goldman Sachs to canvass potential buyers for a carve-out of a portion of its personal care division that could attract proceeds in excess of $1 billion. The move is framed as a po…

Vicor acquires sites for additional ChiP fabs

Vicor acquires sites for additional ChiP fabs

Vicor Corporation is acquiring two large industrial sites in Merrimack and Hooksett, New Hampshire, to build ChiP Fab-2 and Fab-3, significantly increasing its power component manufacturing capacity beyond the current Fab-1 in Massachusetts. This expansion aims to support advanced AI applications by providing scalable, high-performance Vertical Pow…

Athens equities close higher as banks, builders and travel names lead gains

Athens equities close higher as banks, builders and travel names lead gains

Greek shares finished higher on Friday with the Athens General Composite rising 1.07% to a five-year high. Strength in the Banking, Construction and Travel sectors powered the advance. Piraeus Bank and Optima bank recorded multi-year highs, while select property and healthcare names trailed. Commodity moves were mixed, with crude oil sliding and go…